News

RXi Pharmaceuticals Corporation have presented new data, on the company's proprietary self-delivering RNAi compounds developed to target Tyrosinase (TYR) and Collagenase (MMP1).

Not only does the platypus have some odd physical features, an updated version of its genome has also underscored the unusual genetic characteristics that it harbors.

A new study has separately confirmed and significantly built on recent research, identifying mutations of a gene that causes the uncommon but potentially fatal Adams-Oliver syndrome.

After two billion years of simple bacterial and archaeal life reigning on earth, an archaea may have swallowed a bacterium, and become a new creature with enough energy to grow and diversify like never before: the eukaryote.

Successful change in product and commercialization strategy with strong focus on proprietary product portfolio.

WaferGen’s SmartChipTM platform has potential to accelerate pharmaceutical drug discovery and development.

The demand for ever more information by the genomics field began about two decades ago with the advent of microarray technology and has grown exponentially ever since.

Evidence continues to surface that supports the premise that antibiotics which have been out of use could still be effective in treating drug-resistant bacteria.

NRGene, a leader in big data genomic analysis based in Israel, mapped the maize W22’s genome in 34 hours.

Scientists have described the surprising discovery and function of a new DNA modification in insects, worms and algae.